tailieunhanh - Ixazomib in combination with carboplatin in pretreated women with advanced triplenegative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

Triple-negative breast cancer (TNBC) comprises a heterogeneous group of diseases which are generally associated with poor prognosis. | Ixazomib in combination with carboplatin in pretreated women with advanced triplenegative breast cancer a phase I II trial of the AGMT AGMT MBC-10 trial

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN